The elderly population is increasing worldwide, with subjects> 65 years of age constituting
the fastest-growing age group. Furthermore, the elderly face the greatest risk and burden of …

Background Statins have been shown to be beneficial in primary and secondary prevention
settings; however, their role in the elderly remains a clinical conundrum, given that age …

In the much older population (≥ 80 years), the management of cardiovascular diseases
requires specific research to avoid a plain transposition of medical practice from younger …

Abstract Purpose of Review Our aim was to examine the current evidence behind
prescribing statins to individuals over 65 years of age with emphasis on those older than 75 …

Statins have been demonstrated to be beneficial for secondary prevention of cardiovascular
(CV) events also in the elderly. However, a great debate is ongoing about the actual …

BACKGROUND:: Although statins have been demonstrated to be beneficial for secondary
prevention in the elderly, their use for primary prevention has not been well described …

Individuals age> 65 years represent the fastest‐growing subpopulation in the United States.
Although these individuals with the highest cardiovascular risk profile would be anticipated …

Statins have proven benefit in the elderly in those with coronary heart disease and diabetes
mellitus. Future studies exploring statin efficacy in primary prevention for patients older than …

Cardiovascular disease (CVD) is estimated to remain as the main cause of death in
developed nations over the next 30 years, with increased prevalence in the older …

Introduction: Atherosclerotic Cardiovascular Diseases (CVD) are among the most relevant
causes of morbidity and mortality worldwide, especially in aged people. Statins are one of …